基本情報
- 所属
- 自治医科大学 分子病態治療研究センター 遺伝子治療研究部 教授
- 学位
- 医学博士(自治医科大学(JMU))M.D.
- J-GLOBAL ID
- 200901034663759310
- researchmap会員ID
- 1000273320
- 外部リンク
研究キーワード
6研究分野
1経歴
11-
2014年 - 現在
-
2011年 - 2014年
-
2004年 - 2011年
-
1998年 - 2003年
-
1995年 - 1998年
学歴
1-
- 1986年
委員歴
5-
2012年 - 現在
-
2003年
論文
187-
Communications biology 7(1) 642-642 2024年5月27日Alterations in the experience-dependent and autonomous elaboration of neural circuits are assumed to underlie autism spectrum disorder (ASD), though it is unclear what synaptic traits are responsible. Here, utilizing a valproic acid-induced ASD marmoset model, which shares common molecular features with idiopathic ASD, we investigate changes in the structural dynamics of tuft dendrites of upper-layer pyramidal neurons and adjacent axons in the dorsomedial prefrontal cortex through two-photon microscopy. In model marmosets, dendritic spine turnover is upregulated, and spines are generated in clusters and survived more often than in control marmosets. Presynaptic boutons in local axons, but not in commissural long-range axons, demonstrate hyperdynamic turnover in model marmosets, suggesting alterations in projection-specific plasticity. Intriguingly, nasal oxytocin administration attenuates clustered spine emergence in model marmosets. Enhanced clustered spine generation, possibly unique to certain presynaptic partners, may be associated with ASD and be a potential therapeutic target.
-
Molecular neurobiology 2024年4月27日It is established that neurogenesis of dentate gyrus is increased after ischemic insult, although the regulatory mechanisms have not yet been elucidated. In this study, we focused on Ezh2 which suppresses gene expression through catalyzing trimethylation of lysine 27 of histone 3. Male gerbils were injected with adeno-associated virus (AAV) carrying shRNA targeting to Ezh2 into right dentate gyrus 2 weeks prior to forebrain ischemia. One week after ischemia, animals were injected with thymidine analogue to label proliferating cells. Three weeks after ischemia, animals were killed for histological analysis. AAV-mediated knockdown of Ezh2 significantly decreased the ischemia-induced increment of proliferating cells, and the proliferated cells after ischemia showed significantly longer migration from subgranular zone (SGZ), compared to the control group. Furthermore, the number of neural stem cells in SGZ significantly decreased after ischemia with Ezh2 knockdown group. Of note, Ezh2 knockdown did not affect the number of proliferating cells or the migration from SGZ in the non-ischemic condition. Our data showed that, specifically after ischemia, Ezh2 knockdown shifted the balance between self-renewal and differentiation toward differentiation in adult dentate gyrus.
-
Nature Communications 14(1) 2023年11月13日Abstract Although cortical feedback signals are essential for modulating feedforward processing, no feedback error signal across hierarchical cortical areas has been reported. Here, we observed such a signal in the auditory cortex of awake common marmoset during an oddball paradigm to induce auditory duration mismatch negativity. Prediction errors to a deviant tone presentation were generated as offset calcium responses of layer 2/3 neurons in the rostral parabelt (RPB) of higher-order auditory cortex, while responses to non-deviant tones were strongly suppressed. Within several hundred milliseconds, the error signals propagated broadly into layer 1 of the primary auditory cortex (A1) and accumulated locally on top of incoming auditory signals. Blockade of RPB activity prevented deviance detection in A1. Optogenetic activation of RPB following tone presentation nonlinearly enhanced A1 tone response. Thus, the feedback error signal is critical for automatic detection of unpredicted stimuli in physiological auditory processing and may serve as backpropagation-like learning.
-
Journal of molecular and cellular cardiology 180 58-68 2023年7月Sepsis is a life-threatening syndrome, and its associated mortality is increased when cardiac dysfunction and damage (septic cardiomyopathy [SCM]) occur. Although inflammation is involved in the pathophysiology of SCM, the mechanism of how inflammation induces SCM in vivo has remained obscure. NLRP3 inflammasome is a critical component of the innate immune system that activates caspase-1 (Casp1) and causes the maturation of IL-1β and IL-18 as well as the processing of gasdermin D (GSDMD). Here, we investigated the role of the NLRP3 inflammasome in a murine model of lipopolysaccharide (LPS)-induced SCM. LPS injection induced cardiac dysfunction, damage, and lethality, which was significantly prevented in NLRP3-/- mice, compared to wild-type (WT) mice. LPS injection upregulated mRNA levels of inflammatory cytokines (Il6, Tnfa, and Ifng) in the heart, liver, and spleen of WT mice, and this upregulation was prevented in NLRP3-/- mice. LPS injection increased plasma levels of inflammatory cytokines (IL-1β, IL-18, and TNF-α) in WT mice, and this increase was markedly inhibited in NLRP3-/- mice. LPS-induced SCM was also prevented in Casp1/11-/- mice, but not in Casp11mt, IL-1β-/-, IL-1α-/-, or GSDMD-/- mice. Notably, LPS-induced SCM was apparently prevented in IL-1β-/- mice transduced with adeno-associated virus vector expressing IL-18 binding protein (IL-18BP). Furthermore, splenectomy, irradiation, or macrophage depletion alleviated LPS-induced SCM. Our findings demonstrate that the cross-regulation of NLRP3 inflammasome-driven IL-1β and IL-18 contributes to the pathophysiology of SCM and provide new insights into the mechanism underlying the pathogenesis of SCM.
MISC
169-
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 95 688-688 2010年6月
-
JOURNAL OF PHYSIOLOGICAL SCIENCES 60 S37-S37 2010年
-
NEUROSCIENCE RESEARCH 68 E66-E66 2010年
-
NEUROSCIENCE RESEARCH 68 E149-E149 2010年
-
JOURNAL OF GENE MEDICINE 11(12) 1151-1152 2009年12月
-
JOURNAL OF GENE MEDICINE 11(12) 1181-1181 2009年12月
-
JOURNAL OF GENE MEDICINE 11(12) 1155-1155 2009年12月
-
JOURNAL OF GENE MEDICINE 11(12) 1179-1179 2009年12月
-
HUMAN GENE THERAPY 20(11) 1480-1480 2009年11月
-
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 94 432-432 2009年6月
-
MOLECULAR THERAPY 17 S108-S108 2009年5月
-
MOLECULAR THERAPY 17 S70-S70 2009年5月
-
MOLECULAR THERAPY 17 S168-S168 2009年5月
-
NEUROSCIENCE RESEARCH 65 S24-S24 2009年
-
NEUROSCIENCE RESEARCH 65 S242-S242 2009年
-
日本産科婦人科學會雜誌 61(2) 665-665 2009年
-
日本産科婦人科學會雜誌 61(2) 727-727 2009年
-
JOURNAL OF GENE MEDICINE 10(4) 443-444 2008年4月
-
JOURNAL OF GENE MEDICINE 10(4) 478-479 2008年4月
-
BLOOD 110(11) 422A-422A 2007年11月
-
JOURNAL OF GENE MEDICINE 8(12) 1471-1471 2006年12月
-
JOURNAL OF GENE MEDICINE 8(12) 1471-1472 2006年12月
-
JOURNAL OF GENE MEDICINE 8(12) 1464-1464 2006年12月
-
JOURNAL OF GENE MEDICINE 8(12) 1460-1461 2006年12月
-
JOURNAL OF GENE MEDICINE 8(12) 1444-1445 2006年12月
-
JOURNAL OF GENE MEDICINE 8(12) 1463-1464 2006年12月
-
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN 126(11) 1021-1028 2006年11月AAV vector is derived from nonpathogenic virus and has a number of attractive features as a vector for human gene transfer including safety, broad tissue specificity, and low immunogenicity following gene transfer. Moreover, persistent transgene expression (for years) was demonstrated in multiple animal experiments. For these reasons, applications to a wide spectrum of diseases are expected, and several clinical trials have been conducted. Although it is too early to conclude the outcome, the efficacy of treatment was not sufficiently substantiated in most of the trials despite confirming the safety of the vector. These results are primarily due to low levels of transgene expression. One of the approaches to improve this situation is the use of alternative serotypes of AAV. Traditionally, serotype 2 was considered to be a prototype of AAV, and the majority of studies including human clinical trials have been conducted using this serotype. On the other hand, there are five "classical" serotypes, and several have been additionally discovered from tissues of primates including humans. These serotypes are considered to be valuable resources for vector development to overcome the shortcomings of serotype 2. This review focuses on the difference in expression levels and tissue specificity of various serotype-derived vectors and summarizes current status in the treatment of candidate diseases.
-
MOLECULAR THERAPY 13 S131-S131 2006年5月
-
MOLECULAR THERAPY 13 S45-S45 2006年5月
-
MOLECULAR THERAPY 13 S427-S427 2006年5月
-
MOLECULAR THERAPY 13 S12-S12 2006年5月
-
MOLECULAR THERAPY 13 S87-S87 2006年5月
-
JOURNAL OF GENE MEDICINE 8(3) 404-405 2006年3月
-
JOURNAL OF GENE MEDICINE 8(3) 381-382 2006年3月
-
JOURNAL OF GENE MEDICINE 8(3) 395-396 2006年3月
-
JOURNAL OF GENE MEDICINE 8(3) 380-380 2006年3月
-
JOURNAL OF GENE MEDICINE 8(3) 390-391 2006年3月
-
JOURNAL OF GENE MEDICINE 8(3) 395-395 2006年3月
-
JOURNAL OF GENE MEDICINE 8(3) 403-403 2006年3月
-
JOURNAL OF GENE MEDICINE 8(3) 386-386 2006年3月
-
JOURNAL OF GENE MEDICINE 8(3) 395-395 2006年3月
-
JOURNAL OF GENE MEDICINE 8(3) 377-377 2006年3月
書籍等出版物
1共同研究・競争的資金等の研究課題
29-
日本学術振興会 科学研究費助成事業 2023年4月 - 2026年3月
-
日本学術振興会 科学研究費助成事業 2022年4月 - 2025年3月
-
日本学術振興会 科学研究費助成事業 2022年4月 - 2025年3月
-
日本学術振興会 科学研究費助成事業 2020年4月 - 2023年3月
-
日本学術振興会 科学研究費助成事業 2020年4月 - 2023年3月